ORDINARY SHARE LISTING APPLICATION
PERTH, AUSTRALIA / ACCESSWIRE / April 3, 2023 / Centamin plc ("Centamin" or "the Company" or "Group", including its subsidiaries) LSE: CEY / TSX: CEE
The Company wishes to advise that under the terms of the Company's shareholder approved incentive plans shares are required, in the ordinary course of business, to satisfy awards that are due to vest to participants in 2023.
1,982,000 ordinary shares of no par value ("Shares") will be issued and will rank pari passu with the Company's existing ordinary shares. The trustee of the share plans will allocate the vested awards subject to the terms of the share plans.
An application has been made by the Company to the Financial Conduct Authority ("FCA") and the London Stock Exchange ("LSE") for the listing of the Shares to be admitted to the Official List of the FCA and to trading on the LSE. The Shares are expected to be admitted to trading on the LSE from 8:00am BST on 6 April 2023.
Immediately following the share admission, and in accordance with FCA Disclosure Guidance and Transparency Rule 5.6.1, the Company's total issued share capital will comprise of 1,158,432,695 ordinary shares of no par value and each carrying one voting right.
For more details on the Company's share plans, please refer to the 2022 Annual Report and Accounts available on the Company's website: https://www.centamin.com/annual-report-2022/.
This announcement contains ongoing regulated information.
FOR MORE INFORMATION please visit the website www.centamin.com or contact:
Centamin plc Alexandra Barter-Carse, Head of Corporate Communications | FTI Consulting Ben Brewerton / Sara Powell / Nick Hennis +442037271000 |
LEI: 213800PDI9G7OUKLPV84
Company No: 109180
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
SOURCE: Centamin PLC